Clinical trial
Buprenorphine Combination Tablet Feasibility
NCT00000298 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Buprenorphine Combination Tablet Feasibility
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 1995
- Completion date
- Not reported
- Enrollment
- 0
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.